BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

KeyNeurotek AG

KeyNeurotek AG was founded in 2000 in Magdeburg, one of the leading European Centers of Neuroscience. Focused to the development of drugs for the treatment of acute and chronic neurodegenerative disorders of the Central Nervous System (e.g. stroke and Alzheimer disease), the company merges superior expertise in neurobiology, preclinical and clinical drug development, medicinal chemistry and in silico/wet chemistry. KeyNeurotek has established efficient platform technologies for a tissue-based and disease-related functional screening ex and in vivo in order to catalyze the identification and development of highly promising drug candidates. KeyNeurotek's exclusive and HTS-compatible TELOMICSTM ex vivo Robotics represents the first setup for tissue-based high content screening world-wide and the technological basis of our approach to drug development.


Contact Details:
ZENIT-Technology Park Leipziger Str. 44
Magdeburg
D-39120
Germany
Tel:49 (0) 3 91 / 6 11 72 20
Fax:49 (0) 3 91 / 6 11 72 21
Email:info@keyneurotek.de
WWW:

www.keyneurotek.de/




Recent Publications by KeyNeurotek AG:

Low stability of Huntington muscle mitochondria against Ca2+ in R6/2 mice.
OBJECTIVE: The aim of the present work was the detection of Mitochondrial...
28th April, 2006
KeyNeurotek AG, ZENIT Technology Park, Magdeburg, Germany. Ann Neurol. 2006 Feb;59(2):407-11.
DOI Direct Link

BioNews Results for KeyNeurotek AG:

Drug Pipeline Progress - September 15 to 29
Drug Discovery and Development:  Sep 30 2008 8:36PM Matching: keyneurotek ag
KeyNeurotek gets EMEA Orphan Drug status for TBI drug KN38-7271
PharmaBiz:  Sep 26 2008 5:12AM Matching: keyneurotek ag
KeyNeurotek Pharmaceuticals receives orphan drug designation of its lead compound KN38-7271 for the treatment
Checkbiotech:  Sep 22 2008 5:25PM Matching: keyneurotek ag
KeyNeurotek Pharmaceuticals Receives Orphan Drug Designation of its lead compound KN38-7271 for the treatment
Pharma Live:  Sep 22 2008 4:19PM Matching: keyneurotek ag

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 242 times since April 2007, the link to the organisation's website has been followed 61 times

Recent Search Terms used to find this page: keyneurotek huntington | A Keyneurotek | keyneurotek | keyneurotek | keyneurotek | keyneurotek ag | infokeyneurotek.de | .

Search for more companies in Magdeburg

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for KeyNeurotek AG
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.